Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q4 2024 (December 31)6holders −4
0new positions
4sold out
$0.97avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, down 4 from Q3 2024. 0 opened new positions and 4 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($483K), Bank of New York Mellon Corp ($291K) and Sonora Investment Management Group, LLC ($155K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $2.6M |
All 13F filers, Q3 2024 → Q4 2024: 14,870,090 shares sold, net −14,870,090 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 500,000 | $483K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $291K |
| Sonora Investment Management Group, LLC | 0.01% | Reduce -98.7% | 160,000 | $155K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -8.2% | 90,000 | $87K |
| Boussard & Gavaudan Investment Management LLP | 0.01% | Reduce -0.2% | 54,910 | $53K |
| Stephens Inc. | 0.00% | Reduce -48.9% | 23,000 | $22K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.